BCEL - Atreca to sell antibody-related assets and materials to Immunome for $12.5M
2023-12-26 08:47:34 ET
More on Atreca, Immunome, etc.
- Immunome: The Morphimmune Merger And The Pipeline
- Immunome a new outperform at Wedbush on cancer platforms
- Seeking Alpha’s Quant Rating on Atreca
- Historical earnings data for Atreca
- Financial information for Atreca
For further details see:
Atreca to sell antibody-related assets and materials to Immunome for $12.5M